X8R-40791-88341
4 vaccinations
3 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 551 / MN
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
HXN-24933-72927
Child or adolescent in my care · Male · 2021-11-09
6YN-42378-74092
Child or adolescent in my care · Female · 2022-10-03
K3V-71267-94432
Child or adolescent in my care · Male · 2022-10-03
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-02-04
Dose 2 — Pfizer-BioNTech
-
2021-02-15
Registered in v-safe
-
2021-02-15
Survey response — day 7, dose 2MedDRA: Dysgeusia — Feeling: Good · Site: PainFree text: metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-26
- 2021-03-04
- 2021-03-12
- 2021-03-18
- 2021-05-06
- 2021-08-05
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 0, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-14
- 2022-01-04
- 2022-04-01
-
2022-09-11
Dose 4 — Moderna
- 2022-10-03
- 2022-10-03
- 2022-10-24
-
2022-12-11
Survey response — 3 months, dose 4MedDRA: Influenza, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: RSV and InfluenzaMedDRA releases: 2024-11 · check-in free text available
-
2022-12-11
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-09-11 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-11 | Successful 2022-12-12 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): metallic taste in mouth
Release 9 — day 0, dose 3
Systemic reaction (other): Pregnancy
Release 12 — 3 months, dose 4
Symptoms: RSV and Influenza
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release